Fairvalue-Calculator Fairvalue-Calculator
EN DE

Vericel Corporation (VCEL) Fair Value & Analysis

Healthcare · US · Market cap $2.1B

Price$41.69
Fair Value$6.18
Upside-85.2%
Quality95/100
Evidence: High Range $5.14 – $7.71

Fair value as of: Jun 25, 2026

Analysis

Vericel Corporation (VCEL) currently trades at $41.69, while our model-based Fair Value estimate is $6.18 — implying the stock looks roughly 85.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Bur…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Vericel Corporation (VCEL) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $6.18 versus a price of $41.69 — about −85% (overvalued). Model-based estimate, not financial advice.
What is the fair value of VCEL?
Our 21-model fair value for Vericel Corporation is $6.18 (as of Jun 25, 2026), built from audited fundamentals. The current price is $41.69.
What is the quality score of VCEL?
Vericel Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.